|
AU722196B2
(en)
*
|
1995-08-30 |
2000-07-27 |
Genzyme Corporation |
Chromatographic purification of adenovirus and AAV
|
|
US20020088014A1
(en)
*
|
1996-05-31 |
2002-07-04 |
Xiangming Fang |
Minimal adenovirus mediated recombinant vaccine
|
|
CZ438398A3
(cs)
|
1996-07-01 |
1999-03-17 |
Rhone-Poulenc Rorer S. A. |
Způsob přípravy rekombinantních adenovirů
|
|
US7732129B1
(en)
*
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
US20060275781A1
(en)
*
|
2004-11-03 |
2006-12-07 |
Introgen Therapeutics Inc. |
Novel method for the protection and purification of adenoviral vectors
|
|
JP4492826B2
(ja)
|
1996-11-20 |
2010-06-30 |
イントロジェン セラピューティクス，インコーポレイテッド |
アデノウイルスベクターの産生および精製のための改良された方法
|
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US6261823B1
(en)
|
1996-12-13 |
2001-07-17 |
Schering Corporation |
Methods for purifying viruses
|
|
US6989264B2
(en)
*
|
1997-09-05 |
2006-01-24 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
AU752704B2
(en)
*
|
1997-10-24 |
2002-09-26 |
Invitrogen Corporation |
Recombinational cloning using nucleic acids having recombination sites
|
|
US7705602B2
(en)
*
|
1997-11-03 |
2010-04-27 |
Midtronics, Inc. |
Automotive vehicle electrical system diagnostic device
|
|
US20040204381A1
(en)
*
|
1997-11-12 |
2004-10-14 |
Moskal Joseph R |
Detection and treatment of glyco-enzyme-related disease
|
|
US6899870B1
(en)
*
|
1998-03-11 |
2005-05-31 |
Board Of Regents, The University Of Texas System |
Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery
|
|
EE200000605A
(et)
*
|
1998-04-22 |
2002-04-15 |
Genvec, Inc. |
Adenoviiruse efektiivne puhastamine
|
|
WO2000022152A1
(en)
*
|
1998-10-13 |
2000-04-20 |
Avigen, Inc. |
Compositions and methods for producing recombinant adeno-associated virus
|
|
US7691370B2
(en)
*
|
1998-10-15 |
2010-04-06 |
Canji, Inc. |
Selectivity replicating viral vector
|
|
US6689600B1
(en)
*
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
ES2323991T3
(es)
*
|
1998-11-16 |
2009-07-28 |
Introgen Therapeutics, Inc. |
Formulacion de adenovirus para terapia genica.
|
|
US7148035B1
(en)
*
|
1998-11-18 |
2006-12-12 |
Oxford Biomedica (Uk) Limited |
Polypeptide
|
|
US6210922B1
(en)
*
|
1998-11-30 |
2001-04-03 |
National Research Council Of Canada |
Serum free production of recombinant proteins and adenoviral vectors
|
|
FR2788064B1
(fr)
*
|
1998-12-31 |
2003-01-31 |
Aventis Pharma Sa |
Methode de separation de particules virales
|
|
JP2003523169A
(ja)
*
|
1998-12-31 |
2003-08-05 |
アバンテイス・フアルマ・エス・アー |
ウイルス粒子の分離法
|
|
DE60029195T2
(de)
|
1999-02-22 |
2007-06-28 |
Transgene S.A. |
Verfahren zur Gewinnung von purifizierter Virenzusammensetzung
|
|
US6795585B1
(en)
|
1999-07-16 |
2004-09-21 |
Eastman Kodak Company |
Representing digital images in a plurality of image processing states
|
|
AU2911501A
(en)
*
|
1999-12-29 |
2001-07-09 |
Genzyme Corporation |
Method using filtration aids for the separation of virus vectors from nucleic acids and other cellular contaminants
|
|
US6168941B1
(en)
*
|
2000-04-07 |
2001-01-02 |
Genvec, Inc. |
Method of producing adenoviral vector stocks
|
|
CN1429073A
(zh)
*
|
2000-04-28 |
2003-07-09 |
曾根公司 |
使用α－MSH及其衍生物的基因治疗系统和方法
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
TWI289158B
(en)
*
|
2000-08-10 |
2007-11-01 |
Oncolytics Biotech Inc |
Method of producing infectious reovirus
|
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
|
US20020064860A1
(en)
*
|
2000-11-29 |
2002-05-30 |
Schering Corporation |
Method for purifying adenoviruses
|
|
EP1370643A1
(en)
*
|
2001-03-16 |
2003-12-17 |
Oncolytics Biotech, Inc. |
Method of extracting virus from cell culture
|
|
US20040146590A1
(en)
*
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
|
JP4499990B2
(ja)
*
|
2001-03-27 |
2010-07-14 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｈｃｖ感染に有用な組成物および方法
|
|
CA2455499C
(en)
|
2001-08-08 |
2011-06-21 |
The Trustees Of The University Of Pennsylvania |
Method for purification of viral vectors having proteins which bind sialic acid
|
|
WO2003020893A2
(en)
*
|
2001-08-30 |
2003-03-13 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
New adenovirus type 7 vectors
|
|
WO2003023026A1
(en)
*
|
2001-09-06 |
2003-03-20 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
AU2002348151A1
(en)
*
|
2001-11-05 |
2003-05-19 |
Genvec, Inc. |
Viral vector production methods and compositions
|
|
EP1407006B9
(en)
*
|
2001-12-20 |
2006-10-18 |
Bavarian Nordic A/S |
Method for the recovery and purification of poxviruses from infected cells
|
|
KR100451308B1
(ko)
*
|
2001-12-28 |
2004-10-06 |
선바이오(주) |
단백질 의약품 정제 방법에서의 바이러스 제거 방법
|
|
WO2003068933A2
(en)
*
|
2002-02-14 |
2003-08-21 |
Novavax, Inc. |
Optimization of gene sequences of virus-like particles for expression in insect cells
|
|
EP1474533B1
(en)
*
|
2002-02-20 |
2006-04-26 |
Merck & Co., Inc. |
Method of determining adenovirus particle concentration
|
|
US20030186832A1
(en)
*
|
2002-03-15 |
2003-10-02 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Isotropic liquid detergents with improved anti-redeposition
|
|
US20030180936A1
(en)
*
|
2002-03-15 |
2003-09-25 |
Memarzadeh Bahram Eric |
Method for the purification, production and formulation of oncolytic adenoviruses
|
|
US20030175688A1
(en)
*
|
2002-03-15 |
2003-09-18 |
Rukmini Pennathur-Das |
Method for the purification and production of oncolytic adenoviruses
|
|
AU2003220531B2
(en)
*
|
2002-03-29 |
2007-11-01 |
Merck & Co., Inc. |
Large scale methods of producing adenovirus and adenovirus seed stocks
|
|
DK1501921T4
(da)
|
2002-04-30 |
2012-10-08 |
Oncolytics Biotech Inc |
Forbedrede virusrensningsmetoder
|
|
ES2285120T3
(es)
*
|
2002-05-14 |
2007-11-16 |
MERCK & CO., INC. |
Procedimientos de purificacion de adenovirus.
|
|
US20030224354A1
(en)
*
|
2002-05-30 |
2003-12-04 |
Introgen Therapeutics Inc. |
Quantifying viral particles with intrinsic fluorescence
|
|
EP1371723A1
(en)
*
|
2002-06-12 |
2003-12-17 |
Procorde GmbH |
Process for preparing an adenovirus-containing preparation
|
|
US20040219516A1
(en)
*
|
2002-07-18 |
2004-11-04 |
Invitrogen Corporation |
Viral vectors containing recombination sites
|
|
CA2496918A1
(en)
*
|
2002-08-28 |
2004-03-11 |
Introgen Therapeutics Inc. |
Chromatographic methods for adenovirus purification
|
|
CA2500727A1
(en)
*
|
2002-10-03 |
2004-04-15 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
US20050282814A1
(en)
*
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
EP1558748A4
(en)
*
|
2002-11-01 |
2008-10-22 |
Promega Corp |
CELL SYSE COMPOSITIONS, USE METHOD, DEVICE AND KIT
|
|
JP4991108B2
(ja)
|
2002-12-13 |
2012-08-01 |
アルファバックス，インコーポレイティド |
多抗原性アルファウイルス・レプリコン粒子及び方法
|
|
ES2630222T3
(es)
*
|
2002-12-13 |
2017-08-18 |
Alphavax, Inc. |
Partículas alfavíricas y métodos de preparación
|
|
ATE457716T1
(de)
|
2002-12-30 |
2010-03-15 |
Angiotech Int Ag |
Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
|
|
CA2802143C
(en)
|
2003-01-14 |
2018-06-19 |
Dana-Farber Cancer Institute |
Sparc encoding polynucleotide as a cancer therapy sensitizer
|
|
CN1791678A
(zh)
*
|
2003-03-20 |
2006-06-21 |
阿尔法瓦克斯公司 |
改进的甲病毒复制子和辅助构建体
|
|
CA2523792A1
(en)
*
|
2003-05-01 |
2004-11-11 |
Dsm Ip Assets B.V. |
Process for the production of biological substances by perfusion culturing of suspended animal cells
|
|
US20040229335A1
(en)
|
2003-05-15 |
2004-11-18 |
Introgen Therapeutics, Inc. |
Methods and compositions for the production of adenoviral vectors
|
|
JP2007523621A
(ja)
*
|
2003-06-18 |
2007-08-23 |
オニックス ファーマシューティカルズ，インコーポレイティド |
ウイルスを精製するための方法
|
|
PT1651666E
(pt)
*
|
2003-07-11 |
2009-08-28 |
Alphavax Inc |
Vacinas de citomegalovírus à base de alfavírus
|
|
ATE500267T1
(de)
|
2003-07-21 |
2011-03-15 |
Transgene Sa |
Multifunktionelle cytokine
|
|
ATE469984T1
(de)
*
|
2003-12-01 |
2010-06-15 |
Life Technologies Corp |
Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
|
|
JP2007515172A
(ja)
*
|
2003-12-23 |
2007-06-14 |
シェーリング コーポレイション |
無血清培地懸濁培養において安定なａ５４９細胞株を生成するための方法
|
|
CN1922308A
(zh)
*
|
2004-02-23 |
2007-02-28 |
克鲁塞尔荷兰公司 |
病毒纯化方法
|
|
CN100333797C
(zh)
*
|
2005-01-26 |
2007-08-29 |
彭朝晖 |
重组腺病毒p53制品在肿瘤治疗中的新用途
|
|
EP2543376A1
(en)
|
2004-04-08 |
2013-01-09 |
Targegen, Inc. |
Benzotriazine inhibitors of kinases
|
|
AU2005245956B2
(en)
*
|
2004-05-18 |
2011-05-19 |
Alphavax, Inc. |
TC-83-derived alphavirus vectors, particles and methods
|
|
MXPA06014030A
(es)
*
|
2004-06-01 |
2007-10-08 |
Genzyme Corp |
Composiciones y metodos para evitar la agregacion del vector aav.
|
|
US20050287616A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Gross Adam F |
Method of assaying denaturation of proteins
|
|
AU2005276974B2
(en)
|
2004-08-25 |
2012-08-02 |
Targegen, Inc. |
Heterocyclic compounds and methods of use
|
|
DE202004014949U1
(de)
*
|
2004-09-25 |
2004-11-18 |
Techno-Grafica Gmbh |
Vorrichtung zum Wärmebehandeln einer Beschichtung von Flachoffset-Druckplatten
|
|
DE102004049290A1
(de)
*
|
2004-10-09 |
2006-04-20 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von Virusmaterial
|
|
US7901921B2
(en)
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
|
CN100497640C
(zh)
*
|
2004-11-26 |
2009-06-10 |
中国人民解放军军事医学科学院生物工程研究所 |
一种高效生产重组腺病毒载体的方法
|
|
US20060166364A1
(en)
*
|
2004-12-22 |
2006-07-27 |
Introgen, Inc. |
Use of flexible bag containers for viral production
|
|
CN103555670B
(zh)
*
|
2004-12-23 |
2015-08-12 |
米迪缪尼有限公司 |
用于病毒增殖的非致瘤性mdck细胞系
|
|
US20060205080A1
(en)
*
|
2005-03-01 |
2006-09-14 |
David Frey |
Formulations for therapeutic viruses having enhanced storage stability
|
|
EP3312196B1
(en)
|
2005-03-23 |
2019-07-17 |
Genmab A/S |
Antibodies against cd38 for treatment of multiple myeloma
|
|
CA2602944C
(en)
*
|
2005-04-11 |
2015-08-11 |
Crucell Holland B.V. |
Virus purification using ultrafiltration
|
|
MX2007013725A
(es)
*
|
2005-05-05 |
2008-04-09 |
Sensient Flavors Inc |
Produccion de beta-glucanos y mananos.
|
|
JP2008543775A
(ja)
*
|
2005-06-08 |
2008-12-04 |
ターゲジェン インコーポレーティッド |
眼の障害を治療するための方法および組成物
|
|
US20090216452A1
(en)
*
|
2005-07-05 |
2009-08-27 |
Develop Tech Resources |
Energy recovery within a fluid distribution network using geographic information
|
|
NZ567851A
(en)
|
2005-11-01 |
2011-09-30 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8604042B2
(en)
*
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8133900B2
(en)
*
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
JP2009529917A
(ja)
*
|
2006-03-22 |
2009-08-27 |
ヴァイラル ロジック システムズ テクノロジー コーポレーション |
標的ポリペプチドの同定方法および免疫学的疾患の治療のためのその使用
|
|
US7691858B2
(en)
*
|
2006-04-25 |
2010-04-06 |
Targegen, Inc. |
Kinase inhibitors and methods of use thereof
|
|
EP2069480B1
(en)
|
2006-09-15 |
2014-03-19 |
MedImmune, LLC |
Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
|
|
US8420103B2
(en)
|
2007-01-30 |
2013-04-16 |
Transgene S.A. |
Papillomavirus vaccines
|
|
US20080299624A1
(en)
*
|
2007-06-01 |
2008-12-04 |
Edward Heslop |
Continuous fermentation apparatus and method
|
|
NZ582495A
(en)
*
|
2007-06-21 |
2012-05-25 |
Alphavax Inc |
Promoterless cassettes for expression of alphavirus structural proteins
|
|
KR101932027B1
(ko)
*
|
2007-10-08 |
2018-12-24 |
인트렉손 코포레이션 |
가공된 수지상 세포 및 암의 치료를 위한 이의 용도
|
|
CN101998965B
(zh)
|
2007-11-01 |
2014-03-12 |
安斯泰来制药有限公司 |
免疫抑制性多肽与核酸
|
|
US20090253184A1
(en)
*
|
2008-01-23 |
2009-10-08 |
Introgen Therapeutics, Inc. |
Compositions and methods related to an adenoviral trans-complementing cell line
|
|
EP2806037B1
(en)
|
2008-05-13 |
2016-09-21 |
Gen-Probe Incorporated |
Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences
|
|
DK3192874T3
(da)
*
|
2008-06-18 |
2019-12-16 |
Oxford Biomedica Ltd |
Virusoprensning
|
|
BRPI0919252A2
(pt)
*
|
2008-09-24 |
2015-08-11 |
Medimmune Llc |
Métodos para cultivar células, propagação e purificação de vírus
|
|
CA2738024A1
(en)
*
|
2008-09-24 |
2010-04-01 |
Medimmune, Llc |
Methods for purification of viruses
|
|
US20110262483A1
(en)
*
|
2008-11-03 |
2011-10-27 |
Ligocyte Pharmaceuticals, Inc. |
Methods for isolating enveloped virus-based vlps free of infectious agents
|
|
WO2010060719A1
(en)
|
2008-11-03 |
2010-06-03 |
Crucell Holland B.V. |
Method for the production of adenoviral vectors
|
|
EP2435666A2
(en)
*
|
2009-05-26 |
2012-04-04 |
Leviathan Energy Hydroelectric Ltd. |
Hydroelectric in-pipe turbine uses
|
|
WO2011005776A1
(en)
*
|
2009-07-07 |
2011-01-13 |
Sony Corporation |
Microfluidic device
|
|
KR20120052352A
(ko)
|
2009-08-07 |
2012-05-23 |
트랜스진 에스.에이. |
Ｈｂｖ 감염을 치료하는 조성물
|
|
CN102791852B
(zh)
|
2009-10-15 |
2014-05-07 |
克鲁塞尔荷兰公司 |
纯化腺病毒颗粒的方法
|
|
KR101805938B1
(ko)
|
2009-10-15 |
2018-01-10 |
얀센 백신스 앤드 프리벤션 비.브이. |
고밀도 세포 배양액에서 아데노바이러스의 정제 방법
|
|
NZ601324A
(en)
|
2010-01-05 |
2014-10-31 |
Vascular Biogenics Ltd |
Methods for use of a specific anti-angiogenic adenoviral agent
|
|
EP2521777B1
(en)
|
2010-01-05 |
2016-12-28 |
Vascular Biogenics Ltd. |
Compositions and methods for treating glioblastoma gbm
|
|
JP6009357B2
(ja)
*
|
2010-01-12 |
2016-10-19 |
バスキュラー バイオジェニックス リミテッド |
アデノウイルスベクターの生産方法およびそれによって生成されるウイルス調製物
|
|
EP2536829B1
(en)
|
2010-02-15 |
2016-04-06 |
Crucell Holland B.V. |
Method for the production of Ad26 adenoviral vectors
|
|
JP2013523175A
(ja)
*
|
2010-04-14 |
2013-06-17 |
イーエムディー・ミリポア・コーポレーション |
高力価、高純度のウイルスストックの作製方法及びその使用方法
|
|
CN103052399B
(zh)
|
2010-08-12 |
2016-06-29 |
依生生物制药控股有限公司 |
用于减少病毒组合物中dna杂质的方法
|
|
EP2618838A1
(en)
|
2010-09-20 |
2013-07-31 |
Crucell Holland B.V. |
Therapeutic vaccination against active tuberculosis
|
|
US9168292B2
(en)
|
2010-09-27 |
2015-10-27 |
Crucell Holland B.V. |
Heterologous prime boost vaccination regimen against malaria
|
|
US8892184B2
(en)
|
2010-10-18 |
2014-11-18 |
Siemens Medical Solutions Usa, Inc. |
Systems and methods for reducing interference in a dual modality imaging system
|
|
WO2012060847A1
(en)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
EP2461162A1
(en)
|
2010-12-03 |
2012-06-06 |
Texcell, . |
Method for determining the titre of viruses by using infectious standards
|
|
BR112013014457A8
(pt)
|
2010-12-09 |
2017-12-19 |
Pasteur Institut |
usos da enzima 6-metilguanina-dna-metiltrasferase (mgmt, ec 2.1.1.63) para aumentar a produção de proteína heteróloga, bem como vetor de expressão, células recombinantes e polipeptídeo de fusão compreendendo sinal de secreção peptídica e proteína snap
|
|
TWI575070B
(zh)
|
2011-07-12 |
2017-03-21 |
傳斯堅公司 |
Ｈｂｖ聚合酶突變體
|
|
TW201318637A
(zh)
|
2011-09-29 |
2013-05-16 |
Transgene Sa |
免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（一）
|
|
TW201321016A
(zh)
|
2011-09-29 |
2013-06-01 |
Transgene Sa |
免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（二）
|
|
WO2013074501A1
(en)
|
2011-11-14 |
2013-05-23 |
Crucell Holland B.V. |
Heterologous prime-boost immunization using measles virus-based vaccines
|
|
CA2864956C
(en)
|
2012-03-12 |
2021-11-09 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
US9119813B2
(en)
|
2012-03-22 |
2015-09-01 |
Crucell Holland B.V. |
Vaccine against RSV
|
|
AP2014007993A0
(en)
|
2012-03-22 |
2014-10-31 |
Crucell Holland Bv |
Vaccine against RSV
|
|
US9567634B2
(en)
*
|
2012-07-26 |
2017-02-14 |
Vectalys |
Method for detecting or measuring the impact of a viral vector composition on eukaryotic cells and biomarkers used thereof
|
|
WO2014066443A1
(en)
|
2012-10-23 |
2014-05-01 |
Emory University |
Gm-csf and il-4 conjugates, compositions, and methods related thereto
|
|
CN110590916A
(zh)
|
2013-04-25 |
2019-12-20 |
扬森疫苗与预防公司 |
稳定化的可溶性融合前rsv f多肽
|
|
US9520347B2
(en)
|
2013-05-03 |
2016-12-13 |
Honeywell International Inc. |
Lead frame construct for lead-free solder connections
|
|
KR102313153B1
(ko)
|
2013-06-17 |
2021-10-15 |
얀센 백신스 앤드 프리벤션 비.브이. |
안정화된 가용성 예비융합 ｒｓｖ ｆ 폴리펩타이드
|
|
US9956166B2
(en)
|
2013-09-18 |
2018-05-01 |
Sorrento Therapeutics, Inc. |
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
|
|
CN105658806A
(zh)
*
|
2013-10-30 |
2016-06-08 |
默克专利股份公司 |
从复杂样品中分离微生物的方法
|
|
KR20160121562A
(ko)
|
2014-02-20 |
2016-10-19 |
허니웰 인터내셔날 인코포레이티드 |
무연 솔더 조성물
|
|
JP6783143B2
(ja)
|
2014-03-25 |
2020-11-11 |
テルモ ビーシーティー、インコーポレーテッド |
培地の受動的補充
|
|
KR102739894B1
(ko)
|
2014-04-25 |
2024-12-05 |
샤이어 휴먼 지네틱 테라피즈 인크. |
메신저 rna 의 정제 방법
|
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
CN105316296A
(zh)
*
|
2014-06-13 |
2016-02-10 |
亚宝药业太原制药有限公司 |
一种纯化腺病毒颗粒的方法
|
|
KR20170073593A
(ko)
|
2014-09-09 |
2017-06-28 |
유넘 테라퓨틱스 |
키메라 수용체 및 면역 요법에서의 그의 용도
|
|
GB201417042D0
(en)
|
2014-09-29 |
2014-11-12 |
Fkd Therapies Oy |
Method
|
|
CN112553229A
(zh)
|
2014-11-05 |
2021-03-26 |
沃雅戈治疗公司 |
用于治疗帕金森病的aadc多核苷酸
|
|
MX2017006217A
(es)
|
2014-11-14 |
2018-05-02 |
Voyager Therapeutics Inc |
Polinucleotidos moduladores.
|
|
RU2020108189A
(ru)
|
2014-11-14 |
2020-03-11 |
Вояджер Терапьютикс, Инк. |
Композиции и способы лечения бокового амиотрофического склероза (als)
|
|
EP3230441A4
(en)
|
2014-12-12 |
2018-10-03 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
|
SG11201704919SA
(en)
|
2015-01-13 |
2017-07-28 |
Alfa Wassermann Inc |
Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav)
|
|
EP3054007A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
|
|
EP3256156B1
(en)
|
2015-02-13 |
2025-02-12 |
Transgene |
Immunotherapeutic vaccine and antibody combination therapy
|
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
|
SI3283634T1
(sl)
|
2015-04-14 |
2019-08-30 |
Janssen Vaccines & Prevention B.V. |
Rekombinantni adenovirus, ki izraža dva transgena z dvosmernim promotorjem
|
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
|
JP7189014B2
(ja)
|
2015-07-07 |
2022-12-13 |
ヤンセン ファッシンズ アンド プリベンション ベーフェー |
Ｒｓｖに対するワクチン
|
|
US10457708B2
(en)
|
2015-07-07 |
2019-10-29 |
Janssen Vaccines & Prevention B.V. |
Stabilized soluble pre-fusion RSV F polypeptides
|
|
US9663766B2
(en)
|
2015-07-24 |
2017-05-30 |
Bio-Rad Laboratories, Inc. |
Methods for purifying adenovirus vectors
|
|
MX2018004546A
(es)
|
2015-10-16 |
2019-04-15 |
Univ Columbia |
Composiciones y métodos para la inhibicion de antígenos específicos de linaje.
|
|
WO2017075335A1
(en)
|
2015-10-28 |
2017-05-04 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
KR20220041966A
(ko)
|
2016-04-05 |
2022-04-01 |
얀센 백신스 앤드 프리벤션 비.브이. |
안정화된 용해성 융합-전 rsv f 단백질
|
|
BR112018070323A2
(pt)
|
2016-04-05 |
2019-01-29 |
Janssen Vaccines & Prevention Bv |
vacina contra rsv
|
|
ES3054035T3
(en)
*
|
2016-04-14 |
2026-01-28 |
Ferring Ventures Ltd |
Fixed-bed bioreactor with constant-flow pump/tubing system
|
|
EP3722436B1
(en)
*
|
2016-04-14 |
2025-09-24 |
Ferring Ventures Ltd |
Fixed-bed bioreactor with constant-flow pump/tubing system
|
|
US11299751B2
(en)
|
2016-04-29 |
2022-04-12 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
CA3023022A1
(en)
|
2016-05-04 |
2017-11-09 |
Transgene Sa |
Combination therapy with cpg tlr9 ligand
|
|
AU2017267665C1
(en)
|
2016-05-18 |
2023-10-05 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
BR112018073472A2
(pt)
|
2016-05-18 |
2019-08-27 |
Voyager Therapeutics, Inc. |
composições e métodos de tratamento da doença de huntington
|
|
US11965175B2
(en)
|
2016-05-25 |
2024-04-23 |
Terumo Bct, Inc. |
Cell expansion
|
|
IL264119B2
(en)
|
2016-05-30 |
2023-04-01 |
Janssen Vaccines Prevention B V |
f proteins of rsv are stabilized before fusion
|
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
|
EP3472327B1
(en)
|
2016-06-20 |
2020-08-19 |
Janssen Vaccines & Prevention B.V. |
Potent and balanced bidirectional promoter
|
|
EP3484506A1
(en)
|
2016-07-14 |
2019-05-22 |
Janssen Vaccines & Prevention B.V. |
Hpv vaccines
|
|
WO2018044933A1
(en)
|
2016-08-30 |
2018-03-08 |
The Regents Of The University Of California |
Methods for biomedical targeting and delivery and devices and systems for practicing the same
|
|
EP3522920A2
(en)
|
2016-10-10 |
2019-08-14 |
Transgene SA |
Immunotherapeutic product and mdsc modulator combination therapy
|
|
US20180119141A1
(en)
|
2016-10-28 |
2018-05-03 |
Massachusetts Institute Of Technology |
Crispr/cas global regulator screening platform
|
|
US10294452B2
(en)
|
2016-11-22 |
2019-05-21 |
Dao-Yao He |
Lysis, extraction and purification of adeno-associated virus and adenovirus from host cells
|
|
CN108085301B
(zh)
*
|
2016-11-22 |
2021-10-26 |
贺道耀 |
从宿主细胞提取和纯化腺相关病毒和腺病毒的方法及其组分和试剂盒
|
|
WO2018106888A1
(en)
*
|
2016-12-08 |
2018-06-14 |
Temple University-Of The Commonwealth System Of Higher Education |
Small animal models for in vivo testing of polyomavirus therapeutics
|
|
US20190345501A1
(en)
|
2017-02-07 |
2019-11-14 |
Massachusetts Institute Of Technology |
Methods and compositions for rna-guided genetic circuits
|
|
US11629332B2
(en)
|
2017-03-31 |
2023-04-18 |
Terumo Bct, Inc. |
Cell expansion
|
|
CN111108198A
(zh)
|
2017-05-05 |
2020-05-05 |
沃雅戈治疗公司 |
治疗亨廷顿病的组合物和方法
|
|
CA3061652A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
AU2018267971A1
(en)
|
2017-05-17 |
2019-11-07 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against RSV infection
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
CN111132626B
(zh)
|
2017-07-17 |
2024-01-30 |
沃雅戈治疗公司 |
轨迹阵列引导系统
|
|
WO2019028306A2
(en)
|
2017-08-03 |
2019-02-07 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR ADMINISTRATION OF ADENO-ASSOCIATED VIRUSES
|
|
CN107384873A
(zh)
*
|
2017-09-05 |
2017-11-24 |
成都汇宇生物技术有限公司 |
重组腺病毒的纯化方法
|
|
SG11202001458SA
(en)
|
2017-09-15 |
2020-03-30 |
Janssen Vaccines & Prevention Bv |
Method for the safe induction of immunity against rsv
|
|
AU2018338728B2
(en)
|
2017-09-29 |
2025-01-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Rescue of central and peripheral neurological phenotype of Friedreich's Ataxia by intravenous delivery
|
|
CN111479924B
(zh)
|
2017-10-16 |
2024-06-14 |
沃雅戈治疗公司 |
肌萎缩性侧索硬化症(als)的治疗
|
|
US20200237799A1
(en)
|
2017-10-16 |
2020-07-30 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
|
WO2019086463A1
(en)
|
2017-10-30 |
2019-05-09 |
Baxalta GmbH |
Environmentally compatible detergents for inactivation of lipid-enveloped viruses
|
|
CN111527202B
(zh)
*
|
2017-11-08 |
2024-03-29 |
蓝天免疫疗法有限责任公司 |
So3色谱在病毒纯化方法中的应用
|
|
WO2019173434A1
(en)
|
2018-03-06 |
2019-09-12 |
Voyager Therapeutics, Inc. |
Insect cell manufactured partial self-complementary aav genomes
|
|
WO2019210137A1
(en)
|
2018-04-27 |
2019-10-31 |
Voyager Therapeutics, Inc. |
Methods for measuring the potency of aadc viral vectors
|
|
TW202015742A
(zh)
|
2018-05-15 |
2020-05-01 |
美商航海家醫療公司 |
投遞腺相關病毒（ａａｖ）之組成物和方法
|
|
AU2019268330A1
(en)
|
2018-05-15 |
2020-11-26 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of Parkinson's disease
|
|
WO2019222444A2
(en)
|
2018-05-16 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Directed evolution
|
|
EP3793686A1
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
US20210254103A1
(en)
|
2018-07-02 |
2021-08-19 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
|
JP2021529559A
(ja)
|
2018-07-03 |
2021-11-04 |
ソティオ，リミティド ライアビリティ カンパニー |
グルコース輸入を向上させるトランス代謝分子と組み合わせたキメラ受容体及びその治療的使用
|
|
MX2021000810A
(es)
|
2018-07-24 |
2021-04-28 |
Voyager Therapeutics Inc |
Sistemas y metodos para producir formulaciones de terapia genetica.
|
|
SG11202101284UA
(en)
|
2018-08-14 |
2021-03-30 |
Sotio Llc |
Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating krebs cycle and therapeutic uses thereof
|
|
WO2020036869A1
(en)
|
2018-08-16 |
2020-02-20 |
Emd Millipore Corporation |
Closed bioprocessing device
|
|
US11389485B2
(en)
|
2018-08-28 |
2022-07-19 |
Vor Biopharma Inc. |
Genetically engineered hematopoietic stem cells and uses thereof
|
|
CA3113648A1
(en)
|
2018-09-21 |
2020-03-26 |
University Of Connecticut |
Compositions and methods to restore paternal ube3a gene expression in human angelman syndrome
|
|
EP3856762A1
(en)
|
2018-09-28 |
2021-08-04 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
CN119684417A
(zh)
|
2018-10-02 |
2025-03-25 |
沃雅戈治疗公司 |
重新定向aav衣壳的嗜性
|
|
TW202035689A
(zh)
|
2018-10-04 |
2020-10-01 |
美商航海家醫療公司 |
測量病毒載體粒子的效價及強度之方法
|
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
JOP20210106A1
(ar)
|
2018-11-13 |
2023-01-30 |
Janssen Vaccines And Prevention B V |
بروتينات rsv f سابقة الاندماج مستقرة
|
|
WO2020123524A1
(en)
*
|
2018-12-11 |
2020-06-18 |
Erbi Biosystems, Inc. |
Methods of manufacturing cell based products using small volume perfusion processes
|
|
EP3911410A1
(en)
|
2019-01-18 |
2021-11-24 |
Voyager Therapeutics, Inc. |
Methods and systems for producing aav particles
|
|
EP3927833A4
(en)
|
2019-02-21 |
2022-11-30 |
Unleash Immuno Oncolytics, Inc. |
ONCOLYTIC ADENOVIRAL VECTOR AND METHODS OF USE
|
|
CN110093455B
(zh)
*
|
2019-04-27 |
2020-03-17 |
中国医学科学院病原生物学研究所 |
一种呼吸道病毒的检测方法
|
|
US20220243225A1
(en)
|
2019-04-29 |
2022-08-04 |
Voyager Therapeutics, Inc. |
SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
|
|
EP3966227A1
(en)
|
2019-05-07 |
2022-03-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation
|
|
CN112175996A
(zh)
*
|
2019-07-05 |
2021-01-05 |
杭州荣泽生物科技有限公司 |
一种基因治疗载体的制备方法和用途
|
|
WO2021030125A1
(en)
|
2019-08-09 |
2021-02-18 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
EP4022070A1
(en)
|
2019-08-26 |
2022-07-06 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
US20220333133A1
(en)
|
2019-09-03 |
2022-10-20 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
|
EP4058574A4
(en)
*
|
2019-11-15 |
2024-02-07 |
City of Hope |
SYSTEM, DEVICE AND METHOD FOR PRODUCING BIOPRODUCTS WITH HIGH DENSITY CELL RESPIRATOR FOR ENHANCED PRODUCTION OF ADENO-ASSOCIATED VIRUSES
|
|
CN110894494B
(zh)
*
|
2019-11-22 |
2022-09-27 |
广西梧州制药（集团）股份有限公司 |
一种大规模高密度悬浮培养293细胞高产腺病毒的方法
|
|
WO2021202651A1
(en)
|
2020-04-01 |
2021-10-07 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
|
EP4135841A1
(en)
|
2020-04-15 |
2023-02-22 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
|
GB202005732D0
(en)
|
2020-04-20 |
2020-06-03 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
|
IL298001A
(en)
|
2020-05-13 |
2023-01-01 |
Voyager Therapeutics Inc |
Redirecting tropism of adeno-associated virus capsids
|
|
WO2022032153A1
(en)
|
2020-08-06 |
2022-02-10 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
GB202013940D0
(en)
|
2020-09-04 |
2020-10-21 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
|
CN112226418B
(zh)
*
|
2020-09-25 |
2022-07-08 |
阜外华中心血管病医院 |
重组腺相关病毒纯化方法
|
|
JP2023545731A
(ja)
|
2020-10-07 |
2023-10-31 |
アスクレピオス バイオファーマシューティカル， インコーポレイテッド |
肢帯型２ｉ（ｌｇｍｄ２ｉ）を含むジストログリカノパチー障害を処置するためのフクチン関連タンパク質（ｆｋｒｐ）の治療的アデノ随伴ウイルス送達
|
|
CN112293394B
(zh)
*
|
2020-10-30 |
2022-11-25 |
海南德安欣有害生物防治科技有限公司 |
一种捕鼠装置及捕鼠方法
|
|
US20230407328A1
(en)
|
2020-11-02 |
2023-12-21 |
Biomarin Pharmaceutical Inc. |
Process for enriching adeno-associated virus
|
|
GB202019454D0
(en)
*
|
2020-12-10 |
2021-01-27 |
Chancellor Masters And Scholars Of The Univ Of Oxford |
Method for purifying virus
|
|
EP4301768A2
(en)
|
2021-03-03 |
2024-01-10 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
EP4323015A4
(en)
|
2021-04-16 |
2025-10-22 |
Askbio Inc |
RATIONALLY POLYPLOID AAV VIRIONS CROSS THE BLOOD-BRAIN BARRIER AND TRIGGER A REDUCED HUMORAL RESPONSE
|
|
WO2023034980A1
(en)
|
2021-09-03 |
2023-03-09 |
Bomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
WO2023034997A1
(en)
|
2021-09-03 |
2023-03-09 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
EP4396203A1
(en)
|
2021-09-03 |
2024-07-10 |
BioMarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
EP4396201A1
(en)
|
2021-09-03 |
2024-07-10 |
BioMarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
WO2023034990A1
(en)
|
2021-09-03 |
2023-03-09 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
JP2024534894A
(ja)
|
2021-09-03 |
2024-09-26 |
ビオマリン プハルマセウトイカル インコーポレイテッド |
Ａａｖカプシド組成物及び送達方法
|
|
US20250223376A1
(en)
|
2021-09-20 |
2025-07-10 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of her2 positive cancer
|
|
JP2024536859A
(ja)
|
2021-09-27 |
2024-10-08 |
ソティオ バイオテック インコーポレイティド |
解糖経路からグルコース代謝産物を再誘導するトランス代謝分子と組み合わせたキメラ受容体ポリペプチド及びその治療的使用
|
|
WO2023081648A1
(en)
|
2021-11-02 |
2023-05-11 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2023091909A1
(en)
|
2021-11-16 |
2023-05-25 |
Sotio Biotech Inc. |
Treatment of myxoid/round cell liposarcoma patients
|
|
US20250011372A1
(en)
|
2021-11-17 |
2025-01-09 |
Voyager Thrapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
KR20240123828A
(ko)
|
2021-12-16 |
2024-08-14 |
유니버시티 오브 던디 |
알파-시누클레인의 표적화 분해
|
|
US20250346920A1
(en)
|
2022-01-25 |
2025-11-13 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
|
WO2023154693A1
(en)
|
2022-02-08 |
2023-08-17 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
GB202201713D0
(en)
|
2022-02-10 |
2022-03-30 |
Univ Dundee |
An affinity directed phosphatase system for targeted protein dephosphorylation
|
|
CN115354033A
(zh)
*
|
2022-03-25 |
2022-11-18 |
上海碧博生物医药科技有限公司 |
一种细胞裂解液、细胞裂解方法及该方法在收获aav的应用
|
|
CN119487051A
(zh)
|
2022-06-02 |
2025-02-18 |
沃雅戈治疗公司 |
Aav衣壳变体及其用途
|
|
TW202417467A
(zh)
|
2022-06-28 |
2024-05-01 |
美商航海家醫療公司 |
Ａａｖ蛋白殼變異體及其用途
|
|
AR129843A1
(es)
|
2022-07-06 |
2024-10-02 |
Voyager Therapeutics Inc |
Variantes de la cápside de aav y usos de estas
|
|
WO2024040207A1
(en)
|
2022-08-19 |
2024-02-22 |
Sotio Biotech Inc. |
Genetically engineered natural killer (nk) cells with chimeric receptor polypeptides in combination with trans metabolism molecules and therapeutic uses thereof
|
|
EP4572787A1
(en)
|
2022-08-19 |
2025-06-25 |
SOTIO Biotech Inc. |
Genetically engineered immune cells with chimeric receptor polypeptides in combination with multiple trans metabolism molecules and therapeutic uses thereof
|
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
KR20250069606A
(ko)
|
2022-09-15 |
2025-05-19 |
보이저 테라퓨틱스, 인크. |
타우 결합 화합물
|
|
TW202417631A
(zh)
|
2022-09-22 |
2024-05-01 |
美商拜奧馬林製藥公司 |
用ａａｖ基因治療載體治療心肌病
|
|
TW202421788A
(zh)
|
2022-09-22 |
2024-06-01 |
美商拜奧馬林製藥公司 |
用ａａｖ基因療法載體治療致心律不整性心肌病
|
|
WO2024215987A1
(en)
|
2023-04-14 |
2024-10-17 |
Sotio Biotech Inc. |
IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-15/IL-15Rα CONJUGATES
|
|
EP4694916A1
(en)
|
2023-04-14 |
2026-02-18 |
SOTIO Biotech Inc. |
Engineered immune cells for treating cancer in combination with il-2/il-15 receptor ?? agonists
|
|
WO2024226790A1
(en)
|
2023-04-26 |
2024-10-31 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
AU2024265526A1
(en)
|
2023-05-03 |
2025-12-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
WO2024229164A2
(en)
|
2023-05-03 |
2024-11-07 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2024229173A2
(en)
|
2023-05-03 |
2024-11-07 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to ataxin-2
|
|
AU2024265504A1
(en)
|
2023-05-03 |
2025-12-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to cdkl5 deficiency
|
|
TW202444917A
(zh)
|
2023-05-04 |
2024-11-16 |
美商航海家醫療公司 |
Ａａｖ衣殼變異體及其用途
|
|
WO2025030010A1
(en)
|
2023-08-01 |
2025-02-06 |
Vor Biopharma Inc. |
Compositions comprising genetically engineered hematopoietic stem cells and methods of use thereof
|
|
WO2025038795A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2025038805A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
WO2025038796A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to cdkl5 deficiency
|
|
WO2025038430A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
AU2024326270A1
(en)
|
2023-08-16 |
2026-03-19 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to frataxin deficiency
|
|
WO2025038802A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to ataxin-2
|
|
WO2025122530A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
WO2025122532A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to ataxin-2
|
|
TW202540436A
(zh)
|
2023-12-05 |
2025-10-16 |
美商航海家醫療公司 |
用於治療與共濟蛋白(frataxin)缺陷相關之病症之組合物及方法
|
|
WO2025122536A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2025122548A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to cdkl5 deficiency
|
|
WO2025122543A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to syntaxin-binding protein 1 deficiency
|
|
WO2025137219A1
(en)
|
2023-12-21 |
2025-06-26 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2025147436A1
(en)
|
2024-01-03 |
2025-07-10 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
CN117551624A
(zh)
*
|
2024-01-11 |
2024-02-13 |
深圳源兴基因技术有限公司 |
一种基于无血清悬浮扩增的高效回收腺病毒的方法
|
|
WO2025214477A1
(en)
|
2024-04-12 |
2025-10-16 |
Skyline Therapeutics (Shanghai) Co., Ltd. |
Treatment of genetic cardiomyopathies with aav gene therapy vectors
|
|
WO2026028089A1
(en)
|
2024-07-29 |
2026-02-05 |
Novartis Ag |
Compositions and methods for the treatment of lysosomal acid lipase deficiency (lal-d)
|